| Date Initiated by Firm | May 13, 2013 |
| Date Posted | August 26, 2013 |
| Recall Status1 |
Terminated 3 on August 28, 2013 |
| Recall Number | Z-2085-2013 |
| Recall Event ID |
65770 |
| Product Classification |
Bacteriophage and controls, b. Anthracis lysis - Product Code NYQ
|
| Product | HSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2 (Herpes Simplex Virus 2). For use in Clinical laboratories when developing their own diagnostic tests. |
| Code Information |
Catalog #18081020, Lot #1368760 & Lot #1312093 |
| FEI Number |
3003335080
|
Recalling Firm/ Manufacturer |
Life Technologies Corporation 7335 Executive Way Frederick MD 21704-8354
|
| For Additional Information Contact | Nicole Fisher 240-379-4300 |
Manufacturer Reason for Recall | Firm received complaints that HSV-2 primers failed to amplify HSV-2 DNA. |
FDA Determined Cause 2 | Process design |
| Action | Life Technologices sent an Urgent Product Recall letter dated May 13, 2013 by certified mail to all affected customers. The letter identified the product, description of problem, and actions to be taken by the user. Customers were instructed to examine inventory immediately, discontinue use and dispose all affected units. Customers were advised to complete the Customer Response Sheet included for product/quantities consumed, and send e-mail to techsupport@lifetech.com. For questions about the details of this product issue, were instructed to contact Technical Support at 800-955-6288 option 4. |
| Quantity in Commerce | 15 kits |
| Distribution | USA Nationwide Distribution in the states of DE, IA, MN, and NC. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|